Building on this basis, my team engineered high-fidelity Cas13Y with efficient editing and low off-target effects (Nature Biotechnology 2022), laying out the technical foundation for future clinical ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.

The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.

“Our target, though it was 838 million tonnes...we have committed to the ministry (Coal Ministry) of around 822-823 million ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

Cipla projects a mid-FY26 launch for Advair, while the release of Abraxane is contingent on regulatory clearance of the company's Goa facility. Respiratory drug Albuterol faces intensifying ...

In the battle for America's shoppers, Walmart (WMT) is still dominating Target (TGT). The world's biggest retailer continues to gain high-income shoppers in the face of sticky inflation while it ...

Another hypothesis is that acupuncture influences certain activities of cells, particularly via the transport, breakdown, and clearance of “bioactive mediators.” These actions, along with the claimed ...